These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 5739416)

  • 1. [Treatment of peripheral vascular disorders, including thromboembolism and hyperlipemia, using pentose polysulfonic ester].
    Szirmai E; Celander DR
    Angiologia; 1968; 20(2):79-83. PubMed ID: 5739416
    [No Abstract]   [Full Text] [Related]  

  • 2. [Attempts of treatment of peripheral blood circulation disorders including thromboembolic and hyperlipemic conditions with pentosanpolysulfoester (PPE)].
    Szirmai E; Celander DR
    Pharmazie; 1968 Sep; 23(9):501-2. PubMed ID: 4180427
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diagnostic and prognostic importance of vascular fragility. Its present treatment].
    Plauchu M; Molinie C; Savoye B; Arnaud P
    Lyon Med; 1966 Nov; 216(48):1285-90. PubMed ID: 5987777
    [No Abstract]   [Full Text] [Related]  

  • 4. Thromboembolic disease and antithrombotic agents in the elderly. Preface.
    Jacobs LG
    Cardiol Clin; 2008 May; 26(2):xiii-xiv. PubMed ID: 18406990
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fibrinolytic treatment of arterial embolism].
    Dorobisz T; Jaworski Z; Samplawska B; Skóra K; Szydlowski Z
    Pol Tyg Lek; 1969 Apr; 24(15):579-81. PubMed ID: 5801918
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical valuation of "Plasmaclar", a new drug for the treatment of hyperlipaemias (author's transl)].
    Ferrer García JL
    Folia Clin Int (Barc); 1973 Nov; 23(11):782-94. PubMed ID: 4773216
    [No Abstract]   [Full Text] [Related]  

  • 7. [CY 58 in treatment of acute ischemia of the extremities].
    Cassou JM; Henriet P; Vandecasteele J
    Lille Med; 1969 Apr; 14(4):Suppl 3:503-7. PubMed ID: 5355630
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the management of retinal blood circulation disorders due to arteriosclerosis and their sequellae].
    Kager S
    Med Klin; 1967 Sep; 62(38):1466-7. PubMed ID: 5627988
    [No Abstract]   [Full Text] [Related]  

  • 9. On the effectiveness of a combined clarifying-fibrinolytic therapy in the preventive and curative treatment of arteriosclerosis and its sequelae.
    Ferliga G
    G Gerontol; 1966 Jun; 14(6):555-69. PubMed ID: 5989598
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fibrinolytic therapy].
    Beyer J; Schellong S
    Hamostaseologie; 2005 Nov; 25(4):345-55. PubMed ID: 16395484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human fibrinolysin in retinal occlusion.
    Batungbacal RT
    Philipp J Surg Surg Spec; 1966; 21(6):351-3. PubMed ID: 4227281
    [No Abstract]   [Full Text] [Related]  

  • 12. [Indications and possibilities of conservative therapy in the treatment of acute arterial occlusions of the extremities].
    Pollazzon G; Salvadego L; Cinti C
    Acta Anaesthesiol; 1968; 19(6):1181-99. PubMed ID: 5756943
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative studies on prevention of thromboembolism using panthesin-hydergin].
    Schwalbe E; Fauner A
    Med Monatsschr; 1971 Apr; 25(4):185-8. PubMed ID: 4995458
    [No Abstract]   [Full Text] [Related]  

  • 14. [New and future major antithrombotic agents in venous pathology].
    Guex JJ; Coignard F
    Phlebologie; 1990; 43(4):605-7. PubMed ID: 2093912
    [No Abstract]   [Full Text] [Related]  

  • 15. Modulation of endothelium and control of vascular and thrombotic disorders.
    Semin Thromb Hemost; 1988; 14 Suppl():1-114. PubMed ID: 3194767
    [No Abstract]   [Full Text] [Related]  

  • 16. Urokinase in pulmonary thromboembolic disease: a preliminary report.
    Dickie K; de Groot W
    Tex Rep Biol Med; 1967; 25(4):613-24. PubMed ID: 6082233
    [No Abstract]   [Full Text] [Related]  

  • 17. Major bleeding events in stable outpatients with coronary, cerebrovascular or peripheral artery disease: findings from the FRENA registry.
    Gadelha T; Bisbe J; Toril J; Alcalá Pedrajas JN; Monreal M;
    J Thromb Haemost; 2009 Aug; 7(8):1414-6. PubMed ID: 19566549
    [No Abstract]   [Full Text] [Related]  

  • 18. Drugs in the treatment of thrombo-embolic diseases--Part II.
    Bouchier-Hayes D
    Ir Med J; 1983 Mar; 76(3):155-9. PubMed ID: 6345455
    [No Abstract]   [Full Text] [Related]  

  • 19. [When is fibrinolytic therapy indicated?].
    Woitinas F
    Med Klin; 1980 Feb; 75(3):98-107. PubMed ID: 6990218
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombolytic therapy. A review (Part 1 of 2).
    Stewart JH; Olin JW; Graor RA
    Cleve Clin J Med; 1989; 56(2):189-96. PubMed ID: 2659204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.